MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopaminergics"

  • 2026 International Congress

    Transforming Acute Parkinson’s Care: Impact of a Proactive, Specialist-led Front-Door Rapid Response Parkinson’s Service (RRPD)

    N. Silva, K. Ramsay, S. Ulikova (Surron In Ashfield, United Kingdom)

    Objective: To assess whether proactive electronic case finding and front-door specialist review reduced reliance on ICE (Electronic Inpatient Referral) and improved time from admission to…
  • 2026 International Congress

    Delayed Parkinsonism Following Japanese Encephalitis: A Case Report with Dopamine Transporter Imaging and L-dopa/DCI treatment

    R. Yui, Y. Kobayashi, G. Okumura, M. Katagiri, C. Yuzawa, Y. Shimizu (Ina, Japan)

    Objective: To report a case of Japanese encephalitis (JE) presenting with thalamic–midbrain lesions followed by delayed parkinsonism confirmed by dopamine transporter imaging. Background: JE is…
  • 2026 International Congress

    Combination Device-aided therapy in Parkinson’s Disease

    S. Garg, G. Chavira-Hernandez, R. Munhoz, T. Mestre (Ottawa, Canada)

    Objective: To analyse the clinical profile and outcomes of patients with Parkinson’s Disease (PD) on combination Device-Aided Therapies (DAT) of Deep Brain Stimulation (DBS) and…
  • 2026 International Congress

    Sensor-Derived Gait Patterns Predict Motor Progression in Parkinson’s Disease Beyond Baseline Dopamine Transporter Imaging

    H. Park, C. Youm, B. Kim, J. Hwang, M. Kim, S. Cheon, Y. Jeong, B. Jin (Busan, Republic of Korea)

    Objective: To determine whether baseline sensor-derived gait pattern scores provide superior prognostic value compared with baseline dopamine transporter (DAT) imaging for predicting longitudinal gait deterioration…
  • 2026 International Congress

    Pulsatile Striatal Dopamine Dynamics Drive Levodopa Induced Dyskinesia In Advanced Parkinson Disease

    L. Su, A. Li, Z. Li, Y. Guo (Shanghai, China)

    Objective: To determine how pathological striatal dopamine fluctuations relate to dyskinesia and motor output in levodopa induced dyskinesia. Background: Levodopa induced dyskinesia is a major…
  • 2025 International Congress

    Dopamine-Responsive Post-Anoxic Parkinsonism

    T. Liu, J. Ahlskog, J. Bower, O. Kantarci, R. Savica (Rochester, USA)

    Objective: To describe a retrospective case series of five cases of dopamine-responsive post-anoxic parkinsonism. Background: Parkinsonism following hypoxic ischemic damage of the basal ganglia is…
  • 2025 International Congress

    Levodopa Effects In Swedd: Clinical And Kinematic Insights From A Case Report

    D. Birreci, L. Angelini, A. Martini, S. Grandolfo, M. de Riggi, S. Aloisio, M. Bologna (Rome, Italy)

    Objective: To investigate the clinical and neurophysiological effects of levodopa treatment in a patient diagnosed with SWEDD. Background: A subset of patients with clinical features…
  • 2025 International Congress

    Antiparkinson Medication Reduces the Probability of the Multiple Step Saccade Pattern During a Memory-Guided Saccade Task

    M. Munoz, J. Reilly, E. Zou, Y. Rivera, G. Pal, L. Verhagen Metman, L. Goelz, D. Corcos, F. David (Chicago, USA)

    Objective: We wanted to determine how the multiple step saccade pattern responds to antiparkinson medication, as it has been proposed to use this pattern as…
  • 2025 International Congress

    Inpatient Multimodal Intensive Care in Moderately Advanced Parkinson’s Disease: Role Of Medication Adjustment In Outcome Measures

    N. Elayan, L. Rubin, M. Mccrossin, C. Roberts, H. Shakil, A. Di Rocco, M. Ghilardi (Long Island, USA)

    Objective: In this study, we wish to determine whether medication changes play a major role in the improvements observed after in-patient multimodal intensive neurorehabilitation and…
  • 2025 International Congress

    Classification of Medication State in Parkinson’s Disease Patients with and without Fluctuations using Facial Videos

    I. Boura, V. Skaramagkas, G. Karamanis, I. Kyprakis, D. Fotiadis, Z. Kefalopoulou, M. Tsiknakis, C. Spanaki (Heraklion, Crete, Greece)

    Objective: This study presents a unique, interpretable Dual-Stream Transformer model for classifying medication state in patients with Parkinson’s disease (PD) using facial videos. Background: Recent…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley